Team:Groningen/Template/MODULE/project/MBD/results

From 2014.igem.org

(Difference between revisions)
Line 23: Line 23:
</tr>
</tr>
<tr>
<tr>
-
<td>1</td><td>3 h</td><td>something</td><td>something</td><td>something</td>
+
<td>1</td><td>0.4</td><td>0.5</td><td>0.5</td><td>something</td>
</tr>
</tr>
<tr>
<tr>
-
<td>2</td><td>?</td><td>After being applied to the wound. Amount of time for reaching the inhibitory concentrations of nisin, DspB and AiiA to pass the bottom membrane and into the wound. </td>
+
<td>2</td><td>0.4</td><td>0.5</td><td>0.5</td><td>something</td>
</tr>
</tr>
<tr>
<tr>
-
<td>3 </td><td>tbd</td><td>In what quantity does S. aureus need to be detected?</td>
+
<td>3</td><td>0.3</td><td>0.3</td><td>0.3</td><td>something</td>
</tr>
</tr>
<tr>
<tr>
-
<td>4</td><td>tbd</td><td>In what quantity does P. aeruginosa need to be detected?</td>
+
<td>4</td><td>0.2</td><td>0.3</td><td>0.3</td><td>something</td>
</tr>
</tr>
<tr>
<tr>
-
<td>5</td><td>2-16 ng/µL</td><td>This concentration can be used for both MRSA and VRE. Source: Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity ……. Brumfitt, Salton, Hamilton-Miller.</td>
+
<td>5</td><td>1.9</td><td>2.2</td><td>2.4</td><td>something</td>
</tr>
</tr>
<tr>
<tr>
-
<td>6</td><td>tbd</td><td>How much is needed to inhibit growth of PA/SA?</td>
+
<td>6</td><td>1.9</td><td>2.3</td><td>2.4</td><td>something</td>
</tr>
</tr>

Revision as of 02:33, 18 October 2014

Results
 
DesignTnisinTAiiATDspBRating
10.40.50.5something
20.40.50.5something
30.30.30.3something
40.20.30.3something
51.92.22.4something
61.92.32.4something